Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Oral testosterone therapy

Oral testosterone therapy

US Patent 12161651 · Granted Dec 10, 2024

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Hydroxyprogesterone caproate compositions and methods of use in preventing prete2025
Oral allopregnanolone compositions and methods of use2025
Oral allopregnanolone compositions and methods of use2025
(17-)-3-oxoandrost-4-en-17-yl dodecanoate compositions and methods of preparatio2025
(17-)-3-oxoandrost-4-en-17-yl dodecanoate compositions and methods of preparatio2025
(17-)-3-oxoandrost-4-en-17-yl dodecanoate compositions and methods of preparatio2025
Oral (17-β)-3-oxoandrost-4-en-17-yl tridecanoate therapy2025
Oral (17-β)-3-oxoandrost-4-en-17-yl tridecanoate therapy2025
Oral (17-β)-3-oxoandrost-4-en-17-yl tridecanoate therapy2025
Composition and method for oral delivery of androgen prodrugs2025
Composition and method for oral delivery of androgen prodrugs2025
Oral testosterone therapy2025